We serve Chemical Name:2-[[5-(dibutylamino)thiophen-2-yl]methylidene]indene-1,3-dione CAS:212632-34-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-[[5-(dibutylamino)thiophen-2-yl]methylidene]indene-1,3-dione
CAS.NO:212632-34-3
Synonyms:bidd:gt0439
Molecular Formula:C22H25NO2S
Molecular Weight:367.50400
HS Code:
Physical and Chemical Properties:
Melting point:135-137ºC (dec.)(lit.)
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:65.62000
Exact Mass:367.16100
LogP:5.61730
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like bidd:gt0439 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,bidd:gt0439 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,bidd:gt0439 Use and application,bidd:gt0439 technical grade,usp/ep/jp grade.
Related News: Remogliflozin is economical than other similar agents currently available in sodium glucose co-transporter-2 (SGLT2) inhibitors class, which shall help for its better access among middle and low socio-economic strata of the society, he added. 2-[[5-(dibutylamino)thiophen-2-yl]methylidene]indene-1,3-dione manufacturer What is the difference? Raw material refers to chemical compounds that are used as a base to make an API. 2-[[5-(dibutylamino)thiophen-2-yl]methylidene]indene-1,3-dione supplier The rest of South Korea will also consider stopping issuing tourist visas to Chinese nationals, said Park Neung-hoo, the government��s minister of health and welfare. All travelers from China will be separated from the other arrivals for heightened screening at airports. 2-[[5-(dibutylamino)thiophen-2-yl]methylidene]indene-1,3-dione vendor The FDA approval allows Biogen to sell its product over several years – with forecasts for potential annual sales reaching as high $10 billion to $50 billion – until the company completes a required follow-up study. 2-[[5-(dibutylamino)thiophen-2-yl]methylidene]indene-1,3-dione factory The overall competition in China’s specialty drug substance market is relatively moderate, but due to the higher technical barriers and higher entry barriers for new entrants, there will be no obvious intensified competition in the short term.